Investor Relations March 26, 2025 Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3 Read More
Investor Relations March 3, 2025 Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders Read More
Investor Relations February 28, 2025 Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval Read More
Investor Relations February 26, 2025 Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board Read More
Videos February 19, 2025 Inside Nexalin: CEO Mark White on TBI Solutions & Expanding Market Potential Read More
Investor Relations February 10, 2025 Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition Read More
